Literature DB >> 10068710

Evaluation and treatment of childhood obesity.

R Moran.   

Abstract

The prevalence of childhood obesity in the United States has risen dramatically in the past several decades. Although 25 to 30 percent of children are affected, this condition is underdiagnosed and undertreated. Hormonal and genetic factors are rarely the cause of childhood obesity; unnecessary diagnostic evaluations can be avoided with a careful history and physical examination. Because obese children may suffer life-long physical and emotional consequences, it is imperative to discuss prevention with parents during well-child examinations. All obese children should be screened for cardiac risk factors, as well as for possible orthopedic, dermatologic and psychiatric sequelae. Treatment should be initiated when the trend in increasing weight obviously surpasses the trend in increasing height. Treatment plans should include reasonable weight-loss goals, dietary and physical activity management, behavior modification and family involvement, which may include weight loss in the parents. Anorexiant medications are not approved by the U.S. Food and Drug Administration for use in pediatric populations.

Entities:  

Mesh:

Year:  1999        PMID: 10068710

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

Review 1.  Evaluation of Children and Adolescents with Obesity.

Authors:  Vaman Khadilkar; Nikhil Shah
Journal:  Indian J Pediatr       Date:  2021-08-18       Impact factor: 1.967

Review 2.  School-based physical activity programs for promoting physical activity and fitness in children and adolescents aged 6 to 18.

Authors:  Maureen Dobbins; Heather Husson; Kara DeCorby; Rebecca L LaRocca
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

3.  Addressing Pediatric Obesity in Clinic.

Authors:  George G A Pujalte; Isabella Ahanogbe; McKennan J Thurston; Richard O White; Alva Roche-Green
Journal:  Glob Pediatr Health       Date:  2017-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.